FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223410887> ?p ?o ?g. }

• W4223410887 endingPage "813" @default.
• W4223410887 startingPage "807" @default.
• W4223410887 abstract "To describe the progression of pachychoroid neovasculopathy (PNV) into pachychoroid aneurysmal type 1 choroidal neovascularization (PAT1)/polypoidal choroidal vasculopathy (PCV).Retrospective longitudinal cohort study.Patients diagnosed with PNV with a follow-up of ≥2 years.Multimodal imaging, including OCT and fluorescein and indocyanine green angiography, was reviewed for the presence of choroidal neovascularization (CNV), aneurysms within/at the margins of the CNV, and subfoveal choroidal thickness (SFCT).Rate of PNV to PAT1/PCV conversion and risk factors thereof.In total, 37 eyes of 32 patients with PNV with a mean follow-up of 3.3 ± 1.1 years (range, 2.0-5.2) were included in the study. At PNV diagnosis, the mean age was 59.7 ± 8.7 years (range, 38.5-78.0 years) and mean SFCT was 357 ± 92 μm (185-589). During the follow-up, 5 (13.5%) eyes developed aneurysms after a mean 3.4 ± 0.8 years (2.3-4.2), defining PAT1/PCV. The risk of PAT1/PCV conversion was 7.4% at year 3, 13.6% at year 4, and 30.7% at year 5. A mean of 5.2 ± 4.0 to 7.9 ± 3.6 intravitreal anti-VEGF injections were given per year, resulting in a significant reduction of SFCT to 317 ± 104 μm (122-589) (P = 0.0007). The age at diagnosis of PNV was significantly lower in eyes that later went on to develop PAT1/PCV (54.0 ± 5.6 [45.9-60.5] vs. 61.2 ± 8.4 [38.5-78.0] years; P = 0.025). At the end of the follow-up, SFCT had on average decreased by -14.0% ± 17.6% (-55.9% to 23.1%) in the PNV group, whereas it had increased by mean 6.9% ± 4.4% (0.00%-10.8%) in the PAT1/PCV conversion group (P = 0.0025).PNV can develop aneurysms within its type 1 CNV, defining the conversion to PAT1/PCV. In this study, the conversion to PAT1/PCV was seen in 13.5% of eyes, resulting in Kaplan-Meier estimates of risk for conversion of 7.4% at year 3, 13.6% at year 4, and 30.7% at year 5. Younger age at diagnosis of PNV and sustained choroidal thickening despite anti-VEGF therapy might be risk factors for PNV to progress into PAT1/PCV." @default.
• W4223410887 created "2022-04-14" @default.
• W4223410887 creator A5014822188 @default.
• W4223410887 creator A5024110425 @default.
• W4223410887 creator A5029287441 @default.
• W4223410887 creator A5040093603 @default.
• W4223410887 creator A5059286249 @default.
• W4223410887 creator A5078875139 @default.
• W4223410887 creator A5083191480 @default.
• W4223410887 date "2022-09-01" @default.
• W4223410887 modified "2023-10-14" @default.
• W4223410887 title "Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy" @default.
• W4223410887 cites W1522459299 @default.
• W4223410887 cites W1969060903 @default.
• W4223410887 cites W1976433015 @default.
• W4223410887 cites W1987339308 @default.
• W4223410887 cites W2008546516 @default.
• W4223410887 cites W2025287737 @default.
• W4223410887 cites W2047390988 @default.
• W4223410887 cites W2115095003 @default.
• W4223410887 cites W2133351144 @default.
• W4223410887 cites W2167627789 @default.
• W4223410887 cites W2215001098 @default.
• W4223410887 cites W2217120174 @default.
• W4223410887 cites W2276207462 @default.
• W4223410887 cites W2320636939 @default.
• W4223410887 cites W2408303061 @default.
• W4223410887 cites W2438197209 @default.
• W4223410887 cites W2601324695 @default.
• W4223410887 cites W2602302047 @default.
• W4223410887 cites W2609400417 @default.
• W4223410887 cites W2743902174 @default.
• W4223410887 cites W2769653767 @default.
• W4223410887 cites W2791875195 @default.
• W4223410887 cites W2810620275 @default.
• W4223410887 cites W2890285480 @default.
• W4223410887 cites W2894025867 @default.
• W4223410887 cites W2909814657 @default.
• W4223410887 cites W2949011892 @default.
• W4223410887 cites W2949149185 @default.
• W4223410887 cites W2964158106 @default.
• W4223410887 cites W2992556813 @default.
• W4223410887 cites W3013593154 @default.
• W4223410887 cites W3016685372 @default.
• W4223410887 cites W3027020456 @default.
• W4223410887 cites W3048476598 @default.
• W4223410887 cites W3073727042 @default.
• W4223410887 cites W3119687389 @default.
• W4223410887 cites W3164452175 @default.
• W4223410887 cites W4211027220 @default.
• W4223410887 cites W4232841428 @default.
• W4223410887 cites W4249438516 @default.
• W4223410887 doi "https://doi.org/10.1016/j.oret.2022.04.004" @default.
• W4223410887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35398547" @default.
• W4223410887 hasPublicationYear "2022" @default.
• W4223410887 type Work @default.
• W4223410887 citedByCount "7" @default.
• W4223410887 countsByYear W42234108872022 @default.
• W4223410887 countsByYear W42234108872023 @default.
• W4223410887 crossrefType "journal-article" @default.
• W4223410887 hasAuthorship W4223410887A5014822188 @default.
• W4223410887 hasAuthorship W4223410887A5024110425 @default.
• W4223410887 hasAuthorship W4223410887A5029287441 @default.
• W4223410887 hasAuthorship W4223410887A5040093603 @default.
• W4223410887 hasAuthorship W4223410887A5059286249 @default.
• W4223410887 hasAuthorship W4223410887A5078875139 @default.
• W4223410887 hasAuthorship W4223410887A5083191480 @default.
• W4223410887 hasBestOaLocation W42234108871 @default.
• W4223410887 hasConcept C118487528 @default.
• W4223410887 hasConcept C126322002 @default.
• W4223410887 hasConcept C2778257484 @default.
• W4223410887 hasConcept C2780248432 @default.
• W4223410887 hasConcept C2781359195 @default.
• W4223410887 hasConcept C71924100 @default.
• W4223410887 hasConcept C72563966 @default.
• W4223410887 hasConceptScore W4223410887C118487528 @default.
• W4223410887 hasConceptScore W4223410887C126322002 @default.
• W4223410887 hasConceptScore W4223410887C2778257484 @default.
• W4223410887 hasConceptScore W4223410887C2780248432 @default.
• W4223410887 hasConceptScore W4223410887C2781359195 @default.
• W4223410887 hasConceptScore W4223410887C71924100 @default.
• W4223410887 hasConceptScore W4223410887C72563966 @default.
• W4223410887 hasIssue "9" @default.
• W4223410887 hasLocation W42234108871 @default.
• W4223410887 hasLocation W42234108872 @default.
• W4223410887 hasOpenAccess W4223410887 @default.
• W4223410887 hasPrimaryLocation W42234108871 @default.
• W4223410887 hasRelatedWork W1987334421 @default.
• W4223410887 hasRelatedWork W1991419272 @default.
• W4223410887 hasRelatedWork W2079523484 @default.
• W4223410887 hasRelatedWork W2082606620 @default.
• W4223410887 hasRelatedWork W2095345573 @default.
• W4223410887 hasRelatedWork W2125418032 @default.
• W4223410887 hasRelatedWork W2349876608 @default.
• W4223410887 hasRelatedWork W3015481187 @default.
• W4223410887 hasRelatedWork W3140535852 @default.
• W4223410887 hasRelatedWork W59883236 @default.
• W4223410887 hasVolume "6" @default.

• next